open access

Vol 11, No 4 (2006)
Published online: 2006-01-01
Submitted: 2005-11-14
Get Citation

Postoperative adjuvant chemoradiotherapy in patients with rectal cancer. Prognostic factors for locoregional control and survival

Marcin Hetnał, Krzysztof Małecki, Stanisław Korzeniowski
DOI: 10.1016/S1507-1367(06)71062-8
·
Rep Pract Oncol Radiother 2006;11(4):175-182.

open access

Vol 11, No 4 (2006)
Published online: 2006-01-01
Submitted: 2005-11-14

Abstract

Aim

The aim of this study is to assess the results of postoperative radiochemotherapy in pts with rectal cancer, factors influencing prognosis with regard to causes of failure and treatment tolerance.

Materials/Methods

Between 1993 and 2002, 178 pts with Dukes stage B or C rectal cancer received postoperative chemoradiotherapy. Median age was 62; 110 patients were males, 68 were females. Median follow-up time was 45 months. Sixty-nine patients had stage B and 109 had stage C disease. Main endpoints of the analysis were locoregional recurrence-free survival (LRRFS), disease-free survival (DFS) and overall survival (OS). Kaplan-Meier method was used to calculate survival rates. Univariate and multivariate analyses of prognostic factors were performed using log rank test and Cox's proportional hazard method.

Results

The 5-year LRRFS was 73%, DFS was 61% and OS was 65%. Lymph node involvement and method of resection (AR favoured) were the only independent prognostic factors for LRRFS. Lymph node involvement, in particular when four or more were involved, was the independent prognostic factor for DFS. For OS, the independent prognostic factors were infiltration of the pararectal fatty tissue, lymph node involvement in particular when four or more were involved, and total number of chemotherapy cycles (at least six favoured). Radiation therapy was well tolerated in 45% of patients. The most common early reactions were diarrhoea, nausea/vomiting and leucopoenia.

Neither SER (start of any treatment to the end of radiotherapy) nor total treatment time appeared to be of prognostic significance in this group of patients.

Conclusions

Involvement of lymph nodes and method of resection were the only independent prognostic factors for LRRFS. Prognostic factors for OS were infiltration of the pararectal fatty tissue, lymph node metastases, four or more involved lymph nodes, and total number of chemotherapy cycles.

Abstract

Aim

The aim of this study is to assess the results of postoperative radiochemotherapy in pts with rectal cancer, factors influencing prognosis with regard to causes of failure and treatment tolerance.

Materials/Methods

Between 1993 and 2002, 178 pts with Dukes stage B or C rectal cancer received postoperative chemoradiotherapy. Median age was 62; 110 patients were males, 68 were females. Median follow-up time was 45 months. Sixty-nine patients had stage B and 109 had stage C disease. Main endpoints of the analysis were locoregional recurrence-free survival (LRRFS), disease-free survival (DFS) and overall survival (OS). Kaplan-Meier method was used to calculate survival rates. Univariate and multivariate analyses of prognostic factors were performed using log rank test and Cox's proportional hazard method.

Results

The 5-year LRRFS was 73%, DFS was 61% and OS was 65%. Lymph node involvement and method of resection (AR favoured) were the only independent prognostic factors for LRRFS. Lymph node involvement, in particular when four or more were involved, was the independent prognostic factor for DFS. For OS, the independent prognostic factors were infiltration of the pararectal fatty tissue, lymph node involvement in particular when four or more were involved, and total number of chemotherapy cycles (at least six favoured). Radiation therapy was well tolerated in 45% of patients. The most common early reactions were diarrhoea, nausea/vomiting and leucopoenia.

Neither SER (start of any treatment to the end of radiotherapy) nor total treatment time appeared to be of prognostic significance in this group of patients.

Conclusions

Involvement of lymph nodes and method of resection were the only independent prognostic factors for LRRFS. Prognostic factors for OS were infiltration of the pararectal fatty tissue, lymph node metastases, four or more involved lymph nodes, and total number of chemotherapy cycles.

Get Citation

Keywords

rectal cancer; chemoradiotherapy; adjuvant; prognostic factors

About this article
Title

Postoperative adjuvant chemoradiotherapy in patients with rectal cancer. Prognostic factors for locoregional control and survival

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 11, No 4 (2006)

Pages

175-182

Published online

2006-01-01

DOI

10.1016/S1507-1367(06)71062-8

Bibliographic record

Rep Pract Oncol Radiother 2006;11(4):175-182.

Keywords

rectal cancer
chemoradiotherapy
adjuvant
prognostic factors

Authors

Marcin Hetnał
Krzysztof Małecki
Stanisław Korzeniowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl